Scrip

Scrip World Pharmaceutical News - the leading provider of global pharmaceutical news for over thirty years.

Participated at Bio/PharMOS-Bio/PharDOS 2006 

Objective : To encourage mutually beneficial marketing and sales relationships and encourage further subscriptions to Scrip. To learn about the industry's key players and to meet Scrip's subscribers.

About Scrip : Tens of thousands of pharmaceutical professionals worldwide subscribe to Scrip World Pharmaceutical News. Why? Because no other publication covers all aspects of pharma, from biotech developments to M&A activities, in such a succinct, straightforward way. Scrip's unique mix of well-written stories, from journalists based around the world, makes it essential to anyone working in any sector of the global biopharmaceutical industry.

If you are yet to subscribe to Scrip you should know that no other publication offers such complete industry coverage. No other publication provides its coverage in such a digestible style. And no other publication has provided such indispensable information to your industry for over thirty years.

First published in 1972, Scrip remains the most respected source of biopharmaceutical industry news. Accessing information on your industry may be easy. But establishing if this information is reliable is not. The overwhelming amount of communication now available to you makes your need greater than ever for Scrip's exclusive, first-hand reporting from independent journalists. So today 80,000+ of your peers rely on Scrip to tell the truth behind the press releases, to fill in the gaps in the company reports.

Our readers know they are reacting to the most reliable reporting available. Do you?

Interests

• contract pharmaceutical manufacturing
• primary manufacturing (APIs)
• secondary manufacturing or processing
• packaging or labelling of finished products
• branded prescription products
• clinical trial materials (CTS or CTM)
• generic pharmaceutical product
• OTCs or nutraceutical products
• antibiotics or cytotoxic products
• small volume manufacturing
• high containment production facilities
• warehousing, handling or distribution
• legal aspects of contract business
• business services for MBOs or M&As
• business development
• contract development services
• development manufacturing for APIs
• pharmaceutical development services (PDS)
• supply chain logistics / management
• drug delivery systems or technologies
• validation and compliance
• quality control (QC) or QA
• analytical testing and batch release
• regulatory issues (cGMP manufacturing)
• metabolism or bioequivalence services
• business diversification issues
• recruitment or training
• contract biologics manufacturing
• biopharmaceuticals
• vaccines or immunotherapeutics
• monoclonal or polyclonal antibodies
• microbial production technologies
• yeast or fungal production technologies
• mammalian cell culture production
• plant-based production technologies
• insect cell based production
• transgenic production technologies
• batch and fed-batch production
• investment services for life-science
• local or regional government bodies
• consulting services for outsourcing
• bio-process development
• viral expression systems
• continuous fermentation systems
• downstream processing of biologics
• scale-up from pilot to commercial volume
• sterile (aseptic) fill & finish processing
• lyophilisation (freeze-drying) services
• process validation, safety and testing
• diagnostic or point-of-care products
• intellectual property (IP) and patents
• life-science business risk assessment
• asset management services
• press, media or public relations (PR)
• product or service licensing

Activity

• press, media or public relations (PR)